Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):740–750. doi: 10.1158/1055-9965.EPI-10-0718

Table 1.

Comparison of high-level features across models.

Model feature FHCRC MISCAN UMICH
Implementation simulation simulation analytic
Disease states (2 stages) × (2 grades) (3 × 2 stages) × (3 grades) (2 stages) × (2 grades)
local-regional, distant stage T0 T3 local, distant stage local-regional, distant stage
low-moderate, high grade low, moderate, high grade low-moderate, high grade
Progression depends on current PSA level current disease state delay time and mode of detection
Stage progression yes yes yes
Grade progression no yes yes
PSA test sensitivity* output of model endogenous parameter endogenous parameter
Biopsy compliance estimated from PLCO combined with PSA sensitivity combined with PSA sensitivity
Biopsy sensitivity based on literature review combined with PSA sensitivity combined with PSA sensitivity
*

Pr(PSA positive|Disease)

Pr(Biopsy received|PSA positive, Disease)

Pr(Biopsy positive | Biopsy received, Disease)